Synergy Director, Infinite Medical

Cheyanne has spent years spearheading our Synergy Partnership Program, acting as the bridge between cutting-edge science and the providers who bring it to life. From hosting transformative conferences to guiding providers through our exclusive lab portal, she has been the architect of a network that spans the entire United States.

Her dedication ensures that patients everywhere have access to the absolute gold standard in adipose-derived MSCs. Cheyanne doesn’t just onboard partners; she builds a community dedicated to the BEST in regenerative medicine.

It takes a rare individual to balance the compassionate precision of nursing with the rigorous focus of business development.  What makes Cheyanne truly special is her innate ability to lead with unwavering compassion; she doesn’t just see data points or lab portals, she sees the patients and providers behind every interaction. Having been a cornerstone of our organization since the doors first opened, her loyalty is matched only by her warmth. She approaches every partnership with a genuine kindness that turns professional colleagues into a unified community, ensuring that everyone she touches feels seen, supported, and inspired.

Beyond her clinical credentials, Cheyanne offers a unique “human-first” approach to the complex world of regenerative medicine. She acts as a steadfast advocate and guide, simplifying the journey for providers so they can focus on what matters most: healing. Whether she is hosting a national conference or providing one-on-one onboarding, her presence brings a sense of calm and confidence to the process. To work with Cheyanne is to experience a leader who prioritizes integrity and heart, making her the ultimate steward of our Synergy Partnership Program.

in joint pain and mobility for patients receiving stem cell or regenerative injections, especially for knees, shoulders, and lower back conditions.

Regenerative medicine has grown massively, with global use now exceeding 1 million procedures annually, and demand increasing every year.

Patient surveys show that 9 out of 10 patients prefer stem cell–based treatments over surgery or steroid injections due to lower downtime and more natural healing.